Fanny Astruc Diaz
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$2.5MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $2.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 25, 2021 | NIH | STTR Phase I Novel therapeutic target to combat cutaneous lupus | $298K | DERMAXON LLC |
| Aug 29, 2019 | NIH | SBIR Phase I Topical selective T-type blockers for the treatment of pruritus | $225K | DERMAXON LLC |
| Jul 18, 2019 | NIH | SBIR Phase II Selective inhibition of CYP26A1 in the skin for the treatment of ichthyosis | $937K | DERMAXON LLC |
| Feb 28, 2019 | NIH | SBIR Phase II Selective inhibition of CYP26A1 in the skin for the treatment of ichthyosis | $27K | DERMAXON LLC |
| Sep 24, 2018 | NIH | SBIR Phase II Selective inhibition of CYP26A1 in the skin for the treatment of ichthyosis | $536K | DERMAXON LLC |
| May 4, 2018 | NIH | STTR Phase I Topical selective T-type blockers for the treatment of neuropathic pain | $228K | DERMAXON LLC |
| Aug 25, 2016 | NIH | STTR Phase I Selective inhibition of CYP26A1 in the skin for the treatment of ichthyosis | $216K | DERMAXON LLC |
Peer ranks
Federal funding#791
Awards as PI#250
Patents#273
Companies
- DERMAXON LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.